Top 5 Key Takeaways from ECCMID 2019

ECCMID 2019 was held April 13-16, 2018, in Amsterdam, the Netherlands. The conference featured results of new studies on a variety of infectious disease and microbiology topics as well as advancements being made across the fields. Here are 5 key takeaways from the meeting.

Read more about these stories:

• FURI Study Case: Ibrexafungerp Successfully Treats Esophageal Candidiasis
• CAMERA2: Combination Therapy for MRSA Bacteremia Effective but Linked to Higher Mortality, AKI Rates
• Most Patients With UTI Symptoms Receive Antibiotics, Yet Lack Evidence of Infection
• Jose Arribas, MD, on the Challenges That Come With Long-Acting Injectables
• ASPECT-NP: Ceftolozane/Tazobactam Efficacious for Ventilated Nosocomial Pneumonia